Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AXNX - Axonics, Inc.

IEX Last Trade
69.14
0.040   0.058%

Share volume: 282,822
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%
$69.10
0.04
0.06%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
16%
Profitability 0%
Dept financing 8%
Liquidity 75%
Performance 19%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.31%
1 Month
1.06%
3 Months
3.03%
6 Months
1.03%
1 Year
19.13%
2 Year
-2.49%
Key data
Stock price
$69.14
P/E Ratio 
-2,066.38
DAY RANGE
N/A - $69.23
EPS 
-$0.03
52 WEEK RANGE
$48.30 - $69.68
52 WEEK CHANGE
$0.19
MARKET CAP 
3.536 B
YIELD 
N/A
SHARES OUTSTANDING 
51.118 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
0.83
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$229,964
AVERAGE 30 VOLUME 
$294,642
Company detail
CEO: Raymond W. Cohen
Region: US
Website: axonics.com
Employees: 610
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Axonics, Inc. engages in the development and commercialization of sacral neuromodulation (SNM) systems. SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinent.

Recent news